162 related articles for article (PubMed ID: 12359865)
1. Genetic polymorphisms of the human MDR1 drug transporter.
Schwab M; Eichelbaum M; Fromm MF
Annu Rev Pharmacol Toxicol; 2003; 43():285-307. PubMed ID: 12359865
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance.
Marzolini C; Paus E; Buclin T; Kim RB
Clin Pharmacol Ther; 2004 Jan; 75(1):13-33. PubMed ID: 14749689
[TBL] [Abstract][Full Text] [Related]
3. MDR1 gene polymorphisms and clinical relevance.
Li YH; Wang YH; Li Y; Yang L
Yi Chuan Xue Bao; 2006 Feb; 33(2):93-104. PubMed ID: 16529292
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.
Droździk M; Białecka M; Myśliwiec K; Honczarenko K; Stankiewicz J; Sych Z
Pharmacogenetics; 2003 May; 13(5):259-63. PubMed ID: 12724617
[TBL] [Abstract][Full Text] [Related]
5. Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature.
Wolking S; Schaeffeler E; Lerche H; Schwab M; Nies AT
Clin Pharmacokinet; 2015 Jul; 54(7):709-35. PubMed ID: 25860377
[TBL] [Abstract][Full Text] [Related]
6. No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects.
Pauli-Magnus C; Feiner J; Brett C; Lin E; Kroetz DL
Clin Pharmacol Ther; 2003 Nov; 74(5):487-98. PubMed ID: 14586389
[TBL] [Abstract][Full Text] [Related]
7. Expression and function of p-glycoprotein in normal tissues: effect on pharmacokinetics.
Staud F; Ceckova M; Micuda S; Pavek P
Methods Mol Biol; 2010; 596():199-222. PubMed ID: 19949926
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein in the placenta: expression, localization, regulation and function.
Ceckova-Novotna M; Pavek P; Staud F
Reprod Toxicol; 2006 Oct; 22(3):400-10. PubMed ID: 16563694
[TBL] [Abstract][Full Text] [Related]
9. Potential impact of ABCB1 (p-glycoprotein) polymorphisms on avermectin toxicity in humans.
Macdonald N; Gledhill A
Arch Toxicol; 2007 Aug; 81(8):553-63. PubMed ID: 17354009
[TBL] [Abstract][Full Text] [Related]
10. The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.
Siegmund W; Ludwig K; Giessmann T; Dazert P; Schroeder E; Sperker B; Warzok R; Kroemer HK; Cascorbi I
Clin Pharmacol Ther; 2002 Nov; 72(5):572-83. PubMed ID: 12426521
[TBL] [Abstract][Full Text] [Related]
11. The role of the transporter P-glycoprotein for disposition and effects of centrally acting drugs and for the pathogenesis of CNS diseases.
Thuerauf N; Fromm MF
Eur Arch Psychiatry Clin Neurosci; 2006 Aug; 256(5):281-6. PubMed ID: 16783494
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs.
Sakaeda T; Nakamura T; Okumura K
Pharmacogenomics; 2003 Jul; 4(4):397-410. PubMed ID: 12831320
[TBL] [Abstract][Full Text] [Related]
13. Redundancy of biological regulation as the basis of emergence of multidrug resistance.
Shtil AA; Azare J
Int Rev Cytol; 2005; 246():1-29. PubMed ID: 16164965
[TBL] [Abstract][Full Text] [Related]
14. Influence of functional MDR1 gene polymorphisms on P-glycoprotein activity in CD34+ hematopoietic stem cells.
Calado RT; Falcão RP; Garcia AB; Gabellini SM; Zago MA; Franco RF
Haematologica; 2002 Jun; 87(6):564-8. PubMed ID: 12031911
[TBL] [Abstract][Full Text] [Related]
15. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic implications of the MDR-1 gene.
Mealey KL
J Vet Pharmacol Ther; 2004 Oct; 27(5):257-64. PubMed ID: 15500562
[TBL] [Abstract][Full Text] [Related]
17. MDR1 pump: more than a drug transporter comment on "Regulatory polymorphisms of multidrug resistance 1 (MDR1) gene are associated with the development of childhood acute lymphoblastic leukaemia" by Hattori et al. [Leuk. Res. (in press)].
Buda G; Orciuolo E; Maggini V; Galimberti S; Barale R; Rossi AM; Petrini M
Leuk Res; 2008 Feb; 32(2):359-60. PubMed ID: 17727946
[No Abstract] [Full Text] [Related]
18. MDR1 gene polymorphisms may be associated with Behçet's disease and its colchicum treatment response.
Rustemoglu A; Gül Ü; Gümüş-Akay G; Gönül M; Yiğit S; Bozkurt N; Karadağ A; Pişkin E; Sunguroğlu A; Kadıkıran A
Gene; 2012 Sep; 505(2):333-9. PubMed ID: 22705826
[TBL] [Abstract][Full Text] [Related]
19. Functional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1).
Pauli-Magnus C; Kroetz DL
Pharm Res; 2004 Jun; 21(6):904-13. PubMed ID: 15212152
[TBL] [Abstract][Full Text] [Related]
20. Importance of P-glycoprotein at blood-tissue barriers.
Fromm MF
Trends Pharmacol Sci; 2004 Aug; 25(8):423-9. PubMed ID: 15276711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
